Dendritic Cell Numbers in the Blood of HIV-1 Infected Patients Before and After Changes in Antiretroviral Therapy
✍ Scribed by JENNIFER S. FINKE; MICHAEL SHODELL; KOKILA SHAH; FREDERICK P. SIEGAL; RALPH M. STEINMAN
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 321 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0271-9142
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In order to evaluate whether a sustained virologic response to therapy resumption after treatment interruption can be achieved in the setting of virologic failure, we reviewed retrospectively the data relating to 56 human immunodeficiency virus (HIV)‐infected subjects selected from 3,14
## Abstract Mitochondrial DNA (mtDNA) of peripheral blood mononuclear cells (PBMCs) collected from Human immunodeficiency virus 1 (HIV‐1)‐infected patients and healthy controls were measured longitudinally using real‐time polymerase chain reaction to evaluate the effects of antiretroviral agents on
Human immunodeficiency virus type 1 (HIV-1) infected patients treated with combination antiretroviral therapy frequently have the level of HIV-1 RNA detectable in plasma driven below the lower limit of detection of current assays, 50 copies ml(-1). Patients may continue to exhibit viral loads (VLs)
## Abstract The aim of the study was to evaluate the mRNA expression of four relevant ABC‐transporter genes [MDR1 (P‐glycoprotein; Pgp), MRP1, MRP4, and MRP5] in HIV‐positive individuals failing treatment and analyze the association between the levels of their expression and viral load, CD4 cell co